Ramamoorthy, N.Saraswathy, P.Das, M. K.Mehra, K. S.Ananthakrishnan, M.2019-10-302019-10-302002Nuclear Medicine Communications, 2002. Vol. 23: pp. 83-89http://hdl.handle.net/123456789/198124898 bytestext/htmlen153Sm186Renatural Sm2O3 targetenriched 152Sm targetradionuclidic impurities 154Eu and 155Euradionuclide therapyProduction logistics and radionuclidic purity aspects of 153Sm for radionuclide therapyArticle